Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maevad - Mobilisation Active de l'Empan Visuo-Attentionel Pour la Dyslexie

NCT05201235 is registered in ClinicalTrials.gov with Humans Matter as lead sponsor.

NCT NCT05201235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05201235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maevad - Mobilisation Active de l'Empan Visuo-Attentionel Pour la Dyslexie
Lead sponsor
Humans Matter
Phase
Not applicable
Overall status
Completed
Start date
January 17, 2022
Completion date
July 5, 2023
Enrollment
74 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

dyslexia, visual attention span deficit